IHI’s new funding round to include topics on CVD and arthritis
The initiative’s proposals aim to tackle current challenges in health research and innovation
Read Moreby Jen Brogan | Jun 26, 2024 | News | 0
The initiative’s proposals aim to tackle current challenges in health research and innovation
Read Moreby John Pinching | Nov 9, 2022 | News | 0
Data demonstrates that secukinumab shows a significantly longer time to flare versus placebo
Read Moreby John Pinching | Jun 27, 2022 | News | 0
Cosentyx receives expanded approvals in EU for use in childhood arthritic conditions
Read Moreby John Pinching | Apr 29, 2022 | News | 0
NICE urges older people to stop routine painkiller use – over 10 million in the UK suffer a form of arthritis or other joint conditions
Read Moreby John Pinching | Apr 13, 2022 | News | 0
Companies will support a study which provides vital information on arthritis for patient-supporting HCPs
Read Moreby John Pinching | Mar 11, 2022 | News | 0
Treatment demonstrated a good safety profile in the overall patient population during the 12-week induction phase
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
